ArticleScientific reports2025
Targeted molecular generation with latent reinforcement learning.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Machine-Learning-Driven Molecular Design and Structure-Property-Performance Relationships in Pharmaceutical Chemistry.Molecules (Basel, Switzerland) · 2026Review
- Generative Chemistry Platform for Small Molecules Targeting RNA: A Case Study for Chemical Optimization.Computational and structural biotechnology journal · 2026Article
- AI-Driven Enzyme Engineering: Emerging Models and Next-Generation Biotechnological Applications.Molecules (Basel, Switzerland) · 2025Review
- Fast and Accurate Ring Strain Energy Predictions with Machine Learning and Application in Strain-Promoted Reactions.JACS Au · 2025Article
- Optimizing blood-brain barrier permeability in KRAS inhibitors: A structure-constrained molecular generation approach.Journal of pharmaceutical analysis · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Computational methods for generating molecules with specific physiochemical properties or biological activity can greatly assist drug discovery efforts. Deep learning generative models constitute a significant step towards that direction. We introduce a novel approach that utilizes a Reinforcement Learning paradigm, called proximal policy optimization, for optimizing molecules in the latent space of a pretrained generative model. Working in the latent space of a generative model lets us bypass the need for explicitly defining chemical rules when computationally designing molecules. The generation of molecules is achieved through navigating the latent space for identifying regions that correspond to molecules with desired properties. Proximal policy optimization is a state-of-the-art policy gradient algorithm capable of operating in continuous high-dimensional spaces in a sample-efficient manner. We have paired our optimization framework with the latent spaces of two different architectures of autoencoder models showing that the method is agnostic to the underlying architecture. We present results on commonly used benchmarks for molecule optimization that demonstrate that our method has comparable or even superior performance to state-of-the-art approaches. We additionally show how our method can generate molecules that contain a pre-specified substructure while simultaneously optimizing for molecular properties, a task highly relevant to real drug discovery scenarios.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.